作為用於治療增生性疾病的MEK抑制劑的吖丁啶

• 收藏
• 分享

专利权人:

Exelixis Inc.

发明人:

AAY, Naing N,ANAND, Neel Kumar NK,BOWLES, Owen Joseph OJ,BUSSENIUS, Joerg J,COSTANZO, Simona S,CURTIS, Jeffry Kimo JK,DUBENKO, Larisa L,JOSHI, Anagha Abhijit AA,KENNEDY, Abigail R. AR,KIM, Angie Inyou,.艾,.阿南德,.鮑爾斯,.布塞紐斯,.科斯坦佐,.柯蒂斯,.杜本科,.喬希

申请号：

HK16102537.8

公开号：

HK1214595A

申请日:

2016.03.07

申请国别(地区):

HK

年份:

2016

代理人:

摘要：

Disclosed are compounds of Formula (I) and pharmaceutically acceptable salts and solvates thereof. Such compounds are MEK inhibitors and are useful in the treatment of proliferative diseases, such as cancer. Also disclosed are pharmaceutical compositions containing such compounds as well as methods of using the compounds and compositions of the invention in the treatment of cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/